M
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Price:
36.32
CNY
6.35%
Market Closed
Market Cap:
¥14.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
|
CN |
|
Vesync Co Ltd
HKEX:2148
|
US |
|
A
|
AsiaPhos Ltd
SGX:5WV
|
SG |
|
Olympic Cards Ltd
BSE:534190
|
IN |
|
Virinchi Ltd
BSE:532372
|
IN |
|
Lion Copper and Gold Corp
OTC:LCGMF
|
CA |
|
Boral Ltd
ASX:BLD
|
AU |
|
D
|
DS Dansuk Co Ltd
KRX:017860
|
KR |
|
H
|
Hong Ho Precision Textile Co Ltd
TWSE:1446
|
TW |
|
Monami Co Ltd
KRX:005360
|
KR |
|
I
|
IHQ Inc
KRX:003560
|
KR |
|
Supreme Engineering Ltd
NSE:SUPREMEENG
|
IN |
|
W
|
Weng Fine Art AG
XETRA:WFA
|
DE |
|
F
|
Fulongma Group Co Ltd
SSE:603686
|
CN |
|
S
|
Stonehorse Energy Ltd
ASX:SHE
|
AU |
|
U
|
Unicorn Mineral Resources Public Ltd Co
LSE:UMR
|
IE |
Wall Street
Price Targets
Price Targets Summary
Mabwell Shanghai Bioscience Co Ltd
Mabwell Shanghai Bioscience Co Ltd
There are no price targets for Mabwell Shanghai Bioscience Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Mabwell Shanghai Bioscience Co Ltd's stock price target?
Not Available
Mabwell Shanghai Bioscience Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Mabwell Shanghai Bioscience Co Ltd's Revenue forecast?
Projected CAGR
104%
104%
For the last 5 years the compound annual growth rate for Mabwell Shanghai Bioscience Co Ltd's revenue is 47%. The projected CAGR for the next 3 years is 104%.
